|
시장보고서
상품코드
1766575
집단검진 시장 : 제품 유형별, 용도별, 성별, 연령층별, 제공 형태별, 최종사용자별, 지역별Population Screening Market, By Product Type, By Application Area, By Gender, By Age Group, By Delivery Mode, By End User,By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
집단검진 시장은 2025년에는 261억 달러로 추정되며, 2032년에는 377억 7,000만 달러에 달할 것으로 예측되며, 2025년부터 2032년까지 연평균 성장률(CAGR) 5.42%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 261억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR | 5.42% | 2032년 가치 예측 | 377억 7,000만 달러 |
세계 집단검진 시장은 질병의 조기 발견과 예방을 목표로 하는 예방 의료의 중요한 측면으로 부상하고 있습니다. 집단검진은 무증상자를 체계적으로 검사하여 특정 질병에 걸릴 위험이 있는 사람들을 식별하고, 적시에 개입하여 건강 상태를 개선할 수 있도록 합니다. 전 세계가 만성질환의 부담 증가와 의료비 증가에 직면한 상황에서 효과적인 집단검진 프로그램의 중요성은 아무리 강조해도 지나치지 않습니다. 이 시장에는 유전자 검진, 암 검진, 심혈관 검진, 감염 검진 등 다양한 검진 및 검사가 포함됩니다. 인공지능과 유전체학의 통합과 같은 기술 발전으로 집단검진 시장은 향후 몇 년 동안 큰 성장과 혁신을 이룰 준비가 되어 있습니다.
시장 역학:
세계 집단검진 시장은 만성질환의 유병률 증가, 질병 조기 발견에 대한 인식 증가, 예방적 건강 관리를 촉진하기 위한 정부의 노력 등 여러 요인에 의해 주도되고 있습니다. 암, 당뇨병, 심혈관질환과 같은 질병 부담의 증가로 인해 위험에 처한 개인을 식별하고 적시에 개입할 수 있는 효과적인 검진 프로그램의 필요성이 증가하고 있습니다. 또한, 액체 생검, 차세대 시퀀싱, AI를 활용한 이미지 분석 등 검진 기술의 발전은 검진 및 검사의 정확성과 효율성을 높여 시장 성장을 더욱 촉진할 것으로 기대됩니다. 그러나 검진 및 검사와 관련된 높은 비용, 특정 지역의 의료 서비스 접근성 제한, 위양성 결과 및 과잉 진단에 대한 우려 등 시장에는 일정한 억제요인이 존재합니다. 또한, 유전자 검사 및 데이터 프라이버시를 둘러싼 규제적 이슈와 윤리적 고려사항이 시장 성장에 걸림돌이 될 수 있습니다. 그러나 이러한 도전에도 불구하고, 집단검진 시장은 이해관계자들에게 큰 기회를 제공하고 있습니다. 원격의료 및 원격 모니터링 솔루션의 채택이 증가함에 따라 검진 프로그램의 범위가 확대될 수 있으며, 특히 의료 서비스가 부족한 지역에서 검진 프로그램의 범위가 확대될 수 있습니다. 또한, 집단검진과 약리유전체학 및 위험 계층화와 같은 개인화된 의료 접근법을 통합하면, 표적화된 개입이 가능해져 환자의 결과를 최적화할 수 있습니다. 전 세계 의료 시스템이 예방 의료와 비용 효율성에 중점을 두면서 집단검진 시장은 향후 몇 년 동안 상당한 성장과 혁신을 이룰 것으로 예상됩니다.
본 조사의 주요 특징
- 세계의 집단검진 시장을 상세히 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 동안 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 이 보고서는 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개 변수를 기반으로 세계 집단검진 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 집단검진 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 집단검진 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 가정
- 조사 목적
- 가정
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER의 분석
- 인수합병 시나리오
- 업계 동향
제4장 세계의 집단검진 시장, 제품 유형별, 2020-2032년
- 하드웨어 기기
- 검사 서비스
- 결과 분석과 해석
제5장 세계의 집단검진 시장, 용도별, 2020-2032년
- 종양학
- 심장병학
- 면역학
- 신경학
- 유전학과 유전체학
- 내분비학과 대사학
- 감염증
- 생식과 모성 건강
- 소아과·신생아과
- 정신의학과 정신건강
- 혈액학
- 소화기내과
- 신장학
제6장 세계의 집단검진 시장, 성별, 2020-2032년
- 남성
- 여성
제7장 세계의 집단검진 시장, 연령층별, 2020-2032년
- 소아 인구
- 성인 인구
- 노인 인구
제8장 세계의 집단검진 시장, 제공 형태별, 2020-2032년
- 온사이트/시설 기반 검진
- 원격/원격의료 검진
- 이동식 검사 유닛
- 자가 검사/재택
제9장 세계의 집단검진 시장, 최종사용자별, 2020-2032년
- 병원
- 진단 검사실
- 학술조사기관
- 정부 및 공중위생 기관
- 전문 클리닉
- 기타
제10장 세계의 집단검진 시장, 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제11장 경쟁 구도
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- QIAGEN
- Hologic
- PerkinElmer
- Illumina
- Cepheid
- Genomic Health
- Agilent Technologies
- Ortho Clinical Diagnostics
- Becton, Dickinson and Company
- Beckman Coulter
제12장 애널리스트의 추천사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고문헌과 조사 방법
- 참고문헌
- 조사 방법
- 출판사 소개
Population Screening Market is estimated to be valued at USD 26.10 Bn in 2025 and is expected to reach USD 37.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.42% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 26.10 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.42% | 2032 Value Projection: | USD 37.77 Bn |
The global population screening market has emerged as a crucial aspect of preventive healthcare, aiming to detect and prevent diseases at an early stage. Population screening involves the systematic testing of asymptomatic individuals to identify those at risk of developing specific conditions, enabling timely intervention and improved health outcomes. As the world faces an increasing burden of chronic diseases and rising healthcare costs, the importance of effective population screening programs cannot be overstated. This market encompasses various screening tests, including genetic screening, cancer screening, cardiovascular screening, and infectious disease screening, among others. With advancements in technology, such as the integration of artificial intelligence and genomics, the population screening market is poised for significant growth and innovation in the coming years.
Market Dynamics:
The global population screening market is driven by several factors, including the rising prevalence of chronic diseases, increasing awareness about early disease detection, and government initiatives to promote preventive healthcare. The growing burden of diseases such as cancer, diabetes, and cardiovascular disorders has heightened the need for effective screening programs to identify at-risk individuals and enable timely intervention. Moreover, advancements in screening technologies, such as liquid biopsy, next-generation sequencing, and AI-powered imaging analysis, are expected to enhance the accuracy and efficiency of screening tests, further driving market growth. However, the market also faces certain restraints, such as high costs associated with screening tests, limited access to healthcare services in certain regions, and concerns regarding false-positive results and overdiagnosis. Additionally, regulatory challenges and ethical considerations surrounding genetic screening and data privacy may pose obstacles to market growth. Despite these challenges, the population screening market presents significant opportunities for stakeholders. The increasing adoption of telehealth and remote monitoring solutions has the potential to expand the reach of screening programs, particularly in underserved areas. Furthermore, the integration of population screening with personalized medicine approaches, such as pharmacogenomics and risk stratification, can enable targeted interventions and optimize patient outcomes. As healthcare systems worldwide focus on preventive care and cost-effectiveness, the population screening market is expected to witness substantial growth and innovation in the coming years.
Key Features of the Study:
- This report provides in-depth analysis of the global population screening market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global population screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Hologic, PerkinElmer, Illumina, Cepheid, Genomic Health, Agilent Technologies, Ortho Clinical Diagnostics, Becton, Dickinson and Company, and Beckman Coulter.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global population screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global population screening market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Hardware Equipment
- Diagnostic Devices
- Sample Collection Devices
- Imaging Equipment
- Testing or Laboratory Services
- Laboratory Testing Kits
- Point-of-Care Testing
- Blood and Urine Testing Services
- Analytics or Interpretation
- Software Solutions for Data Analysis
- Interpretation Services
- Reporting Tools
- Others
- Application Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Cardiology
- Immunology
- Neurology
- Genetics and Genomics
- Endocrinology and Metabolism
- Infectious Diseases
- Reproductive and Maternal Health
- Pediatrics and Neonatology
- Psychiatry and Mental Health
- Hematology
- Gastroenterology
- Nephrology
- Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Population
- Adult Population
- Elderly Population
- Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
- Onsite/Facility-Based Screening
- Remote/Telehealth Screening
- Mobile Screening Units
- Self-Testing/Home-Based
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
- Government and Public Health Agencies
- Specialty Clinics
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- QIAGEN
- Hologic
- PerkinElmer
- Illumina
- Cepheid
- Genomic Health
- Agilent Technologies
- Ortho Clinical Diagnostics
- Becton, Dickinson and Company
- Beckman Coulter
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Population Screening Market, By Product Type
- Global Population Screening Market, By Application Area
- Global Population Screening Market, By Gender
- Global Population Screening Market, By Age Group
- Global Population Screening Market, By Delivery Mode
- Global Population Screening Market, By End User
- Global Population Screening Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Population Screening Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hardware Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Devices
- Sample Collection Devices
- Imaging Equipment
- Testing or Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Laboratory Testing Kits
- Point-of-Care Testing
- Blood and Urine Testing Services
- Analytics or Interpretation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Software Solutions for Data Analysis
- Interpretation Services
- Reporting Tools
- Others
5. Global Population Screening Market, By Application Area, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetics and Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Endocrinology and Metabolism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Reproductive and Maternal Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pediatrics and Neonatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Psychiatry and Mental Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nephrology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Population Screening Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Population Screening Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Elderly Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Population Screening Market, By Delivery Mode, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Onsite/Facility-Based Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Remote/Telehealth Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Mobile Screening Units
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Self-Testing/Home-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Population Screening Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Government and Public Health Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Population Screening Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cepheid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genomic Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ortho Clinical Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beckman Coulter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
샘플 요청 목록